Apoptosis in cancer - an update

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 4873-4878

  Leena Sankari, S ^a   Masthan, K M K ^a   Aravindha Babu, N ^a   Bhattacharjee, Tathagata ^a   Elumalai, M ^a  

^a SREE BALAJI DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

Apoptosis; Cancer; Caspases; Detection

Indexed keywords

EID: 84874007675     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.4873     Document Type: Short Survey

References (37)

1. Abou-Nassar K, Brown JR (2010). Novel agents for the treatment of chronic lymphocytic leukaemia. Clin Adv Haematol Oncol, 8, 886-95.
2. Apoptosis Detection Guide (2010). Enzo Life Sciences Inc. International edition. pp1-14.
3. Ataur Rahman, Tipu Sultan, Rokibul Islam (2012). Apoptosis and cancer: insights molecular mechanisms and treatments. Int J Biomol and Biomed, 2,1-16.
4. Boeckler FM, Joerger AC, Jaggi G, et al (2008). Targeted rescue of a destabilised mutant of p53 by an in silico screened drug. Proc Natl Acad Sci USA, 105, 10360-5.
5. Cheung H-H, Liu X, Rennert OM (2012). Apoptosis: Reprogramming and the fate of mature cells, ISRN Cell Biology, 2012, 1-8.
6. Curtin JF, Cotter TG (2003). Apoptosis: historical perspectives. Essays Biochem, 39, 1-10.
7. Deveraux QL, Takahashi R, Salvesen GS, et al (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature, 388, 300-4.
8. Dai Y, Lawrence TS, Xu L (2009). Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B. Am J Tranl Res, 1, 1-15.
9. Dewson G, Kluc RM,(2010) Bcl-2 family-regulated apoptosis in health and disease. Cell Hlth and Cytoskeleton, 2, 9-22.
10. Elmore S (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol, 35, 495-516.
11. Gewies A (2003). Apo Review - Introduction to Apoptosis: pp1-26
12. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
13. Hassen S, Ali N, Chowdhury P (2012) Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer. World J Gastrointest Pathophysiol, 3, 7-79.
14. Horvitz HR (1999). Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res, 59, 1701-6.
15. Holdenrieder S, Stieber P (2004). The potential of apoptotic markers in diagnostic oncology: as featured in CLI December 2004.
16. Imawati B, Holt O, Michael L, et al (1999). Biochemical pathways of caspase activation during apoptosis annu. Rev Cell Dev Biol, 15, 269-90.
17. Kerr JF, Wyllie AH, Currie AR (1972). Apoptosis: a basic, biological phenomenon with wide ranging implications, in tissue kinetics. Br J Cancer, 26, 239-57.
18. Krejci P, Pejchalova K, Rosenbloom BE, et al (2007). The antiapoptotic protein Api5, and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia. J Leukoc Bio, 82, 1363-4.
19. Masthan KMK, AravindhaBabu N, Kailash CD, et al (2012)Advanced diagnostic aids in oral cancer. Asian Pac J Cancer Prev, 13, 1-4.
20. Morris EJ, Michaud WA, Ji JY, et al (2006). Functional identification of Api5 as a suppressor of E2Fdependent apoptosis in vivo. PLoS Genetics, 2, 196.
21. Quinn L, Deveraux, John C Reed (1999). IAP family proteins- -suppressors of apoptosis. Genes Dev, 13, 239-52.
22. Rai KR, Moore J, Wu J, et al (2008). Effect of the addition of oblimersen (Bcl-2 antisense) to fludarabine/cyclophosphamide for replased/refractory chronic lymphocytic leukaemia (CLL) on survival in patients who achieve CR/nPR: Five-year follow-up from a randomized phase III study. J Clin Oncol, 26, 7008.
23. Ramírez CR, Carracedo AJ, Moreno Aguilary FC, et al (1999). Apoptosis and disease. Alergol Inmunol Clin, 14, 367-4.
24. Rebecca SY Wong (2011). Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res, 30, 1-14.
25. Roy N, Deveraux QL, Takahashi R, et al (1997). The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBOJ, 16, 6914-25.
26. Rigou P,Piddubnyak V,Faye A et al (2009). The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentation: The EMBO Journal, 28, 1576-88.
27. Sasaki H, Moriyama S, Yukiue H, et al (2001). Expression of theantiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer. Lung Cancer, 34, 53-7.
28. Schroder M, Kaufman RJ (2005). The mammalian unfolded protein response. Annu Rev Biochem, 74, 739-89.
29. Searle J, Kerr JFR, Bishop CJ (1982). Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu, 17, 229-59.
30. Seshagiri S, Miller LK (1997). Baculovirus inhibitors of apoptosis (IAPs) block activation of Sf-caspase-1. Proc Natl Acad Sci USA, 94, 13606-11.
31. Szegezdi E, Fitzgerald U, Samali A (2003). Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann NY Acad Sci, 1010, 186-94.
32. Szegezdi E, Logue SE, Gorman AM, et al (2006). Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep, 7, 880-5.
33. Tewari M, Yu M, Ross B, et al (1997). AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res, 57, 4063-9.
34. Tiwari.(2012) Journal of Cancer Therapeutics and Research, pp1 -10)http://www.hoajonline.com/journals/jctr/content/ pdf/3.pdf.
35. Van den Berghe L, Laurell H, Huez I et al (2000). FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor],a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. Mol Endocrinol (Baltimore, Md), 14, 1709-24.
36. World Health Organization (2010). Cancers the problem, NMH Fact sheet January.
37. Zinszner H, Kuroda M, Wang X, et al (1998). CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev, 12, 982-95